Share on LinkedInShare on LinkedIn

ARTICLE · 05 NOVEMBER 2014

PTAB Designates Seven Recent Decisions As Informative

ZTE Corp. v. ContentGuard Holdings, Inc.; Intelligent Bio-Systems, Inc. v. Illumina Cambridge Limited; Medtronic, Inc. v. Robert Bosch Healthcare Systems, Inc.; Unilever, Inc. v. Proctor & Gamble Co.; Prism Pharma Co., Ltd. v. Choongwae Pharma Corporation; Unified Patents, Inc. v. Personal Web Technologies, LLC and Level 3 Communications, LLC; and Medtronic, Inc. v. Nuvasive, Inc.

United StatesIntellectual Property

ZTE Corp. v. ContentGuard Holdings, Inc.; Intelligent Bio-Systems, Inc. v. Illumina Cambridge Limited; Medtronic, Inc. v. Robert Bosch Healthcare Systems, Inc.; Unilever, Inc. v. Proctor & Gamble Co.; Prism Pharma Co., Ltd. v. Choongwae Pharma Corporation; Unified Patents, Inc. v. Personal Web Technologies, LLC and Level 3 Communications, LLC; and Medtronic, Inc. v. Nuvasive, Inc.

The Patent Trial and Appeal Board (PTAB) recently designated seven decisions from inter partes review (IPR) proceedings as informative opinions: ZTE Corp. v. ContentGuard Holdings, Inc., Case No. IPR2013-00454 (PTAB, Sept. 25, 2013) (Kim, APJ); Intelligent Bio-Systems, Inc.  v. Illumina Cambridge Limited, Case No. IPR2013-00324 (PTAB, Nov. 21, 2013) (Crumbley, APJ); Medtronic, Inc. v. Robert Bosch Healthcare Systems, Inc., Case No. IPR2014-00436 (PTAB, June 19, 2014) (Quinn, APJ); Unilever, Inc. v. Proctor & Gamble Co., Case No. IPR2014-00506 (PTAB, July 7, 2014) (Obermann, APJ); Prism

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from